You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

deferasirox

Showing 26 - 50 of 114
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

Completed
  • Thalassemia, Beta
  • Hydroxyurea and Thalidomide
  • Karachi, Sindh, Pakistan
    Children's Hospital Karachi
Nov 23, 2023

Aplastic Anemia Trial in Moscow (ICL670, Chelation, No chelation)

Terminated
Has Results
  • Aplastic Anemia
  • Moscow, Russian Federation
    Novartis Investigative Site
Jul 8, 2019

Transfusion-dependent Iron Overload Trial in Worldwide (Deferasirox)

Completed
  • Transfusion-dependent Iron Overload
  • Deferasirox
  • Adelaide, Australia
  • +97 more
Feb 8, 2020

Different Risk Factors on Growth Parameters of Thalassemic

Not yet recruiting
  • Thalassemia Major
  • serum ferritin and AST
  • (no location specified)
Mar 29, 2022

Beta Thalassemia Major Trial in Tirana (Emeramide)

Completed
  • Beta Thalassemia Major
  • Tirana, Albania
    University Hospital Center "Mother Theresa" Tirana
Aug 20, 2021

Iron Overload, Oxidative Stress, Thalassemia Major Trial in Bani Suwayf, Mecca (Omega 3, Nigella Sativa Oil, Hydroxyurea)

Completed
  • Iron Overload
  • +2 more
  • Omega 3
  • +5 more
  • Banī Suwayf, Egypt
  • +3 more
Jan 25, 2021

Myelodysplastic Syndrome Trial in Liege (Bone marrow aspirate, Deferasirox)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • Bone marrow aspirate
  • Deferasirox
  • Liege, Belgium
    Novartis Investigative Site
Jul 24, 2018

Low and Int 1-risk Myelodysplastic Syndrome Trial in Worldwide (Deferasirox DFX, DT, Erythropoietin alpha, Deferasirox DFX, FCT)

Completed
Has Results
  • Low and Int 1-risk Myelodysplastic Syndrome
  • Deferasirox DFX, DT
  • +2 more
  • Oran, Algeria
  • +29 more
Oct 4, 2018

Postmenopausal Osteoporosis Trial in Suzhou (Deferasirox and calcium-vitamin D3, Calcium-vitamin D3)

Unknown status
  • Postmenopausal Osteoporosis
  • Deferasirox and calcium-vitamin D3
  • Calcium-vitamin D3
  • Suzhou, Jiangsu, China
    Second Affiliated Hospital of Soochow University
May 13, 2018

Liver Fibrosis in Sickle Cell Disease

Completed
  • Sickle Cell Disease
  • Liver transient elastography (Fibroscan)
  • +2 more
  • Miami, Florida
    University of Miami
May 21, 2021

MDS Trial in Toronto (Deferasirox + Azacitidine, Azacitidine)

Terminated
  • Myelodysplastic Syndromes
  • Toronto, Ontario, Canada
    Odette Cancer Centre, Sunnybrook Health Sciences Centre
Apr 24, 2018

Thalassemia in Children Trial in Alexandria (Benson's Relaxation technique, Music therapy)

Active, not recruiting
  • Thalassemia in Children
  • Benson's Relaxation technique
  • Music therapy
  • Alexandria, Egypt
    the Hematology Out-Patient Clinic of the Children's University H
Feb 13, 2023

Erythroid Response in Myelodysplasia Undergoing Chelation

Unknown status
  • Myelodysplasia
  • +2 more
    • Alessandria, AL, Italy
    • +19 more
    Jul 29, 2019

    Breast Cancer, Iron Overload, Leukemia Trial in Minneapolis (deferasirox)

    Terminated
    Has Results
    • Breast Cancer
    • +7 more
    • deferasirox
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Dec 3, 2017

    MDS Trial in Belgium, France (Deferasirox, Vitamin D and Azacitidine)

    Unknown status
    • MDS
    • Deferasirox, Vitamin D and Azacitidine
    • Gent, Belgium
    • +14 more
    Jan 9, 2018

    Satisfaction in ß-Thalassemia Patients Receiving Deferasirox

    Unknown status
    • β-thalassemia
    • The Medical Outcomes Short-Form 36-Item Health Survey (SF-36v2) It
    • Assiut, Egypt
      Assiut University Hospital
    Nov 27, 2017

    Beta-thalassemia, MDS, Fanconi Syndrome Trial in United States (Deferasirox)

    Completed
    • Beta-thalassemia
    • +4 more
    • Deferasirox
    • Oakland, California
    • +5 more
    Aug 17, 2017

    Erythrocyte Transfusion, Beta-Thalassemia Trial in Worldwide (Luspatercept, Placebo)

    Completed
    Has Results
    • Erythrocyte Transfusion
    • Beta-Thalassemia
    • Los Angeles, California
    • +72 more
    Jan 21, 2022

    MDS Trial in Belgium

    Unknown status
    • Myelodysplastic Syndromes
      • Bonheiden, Antwerpen, Belgium
      • +20 more
      Aug 9, 2019

      Sickle Cell Anemia Trial (Hydroxyurea)

      Terminated
      Has Results
      • Sickle Cell Anemia
      • (no location specified)
      Jul 9, 2020

      Thalassemia (Transfusion Delendent) Trial (deferasirox)

      Withdrawn
      • Thalassemia (Transfusion Delendent)
      • deferasirox
      • (no location specified)
      Apr 19, 2017

      Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD Trial (Deferasirox)

      Withdrawn
      • Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
      • Deferasirox
      • (no location specified)
      Apr 19, 2017

      ß-thalassemia Major Trial (Deferasirox)

      Withdrawn
      • β-thalassemia Major
      • Deferasirox
      • (no location specified)
      Apr 19, 2017

      MDS, Transfusion Dependent Iron Overload Trial in Berlin (ICL670/Deferasirox)

      Completed
      • Myelodysplastic Syndromes
      • Transfusion Dependent Iron Overload
      • Berlin, Germany
        Novartis Investigative Site
      May 30, 2017

      Pulmonary Hypertension Risk in Beta Thalassemia Major Children

      Completed
      • Thalassemia in Children
      • +2 more
      • blood sample
      • Tricuspid regurge velocity
      • Assiut, Egypt
        Assiut University
      Aug 26, 2019